The Patent Finder

Benzimidazole Derivatives as PI3 Kinase Inhibitors

GlaxoSmithKline LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 14/164,414, filed Jan 27, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,062,003Benzimidazole Derivatives as PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn force
High confidence
US 9,156,797Benzimidazole Derivatives As PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn force
High confidence
US 10,314,845Benzimidazole Derivatives as PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn force
High confidence
US 10,660,898Benzimidazole Derivatives as PI3 Kinase Inhibitors
In force
 · High confidence
GlaxoSmithKline LLCIn force
High confidence
US 9,872,860Benzimidazole Derivatives As PI3 Kinase Inhibitors
Lapsed Jan 23, 2026 on the fee record
Ended Jan 23, 2026 · High confidence
GlaxoSmithKline LLCLapsed Jan 23, 2026 on the fee recordEnded Jan 23, 2026
High confidence
US 8,674,090Benzimidazole Derivatives As PI3 Kinase Inhibitors
Lapsed Mar 18, 2026 on the fee record
Ended Mar 18, 2026 · High confidence
GlaxoSmithKline LLCLapsed Mar 18, 2026 on the fee recordEnded Mar 18, 2026
High confidence
US 8,865,912Benzimidazole Derivatives As PI3 Kinase Inhibitors
Lapsed Oct 21, 2026 on the fee record
Ended Oct 21, 2026 · Low confidence
GlaxoSmithKline LLCLapsed Oct 21, 2026 on the fee recordEnded Oct 21, 2026
Low confidence
Application 13/876,853Benzimidazole Derivatives as PI3 Kinase Inhibitors
Abandoned
Abandoned Sep 24, 2013
GlaxoSmithKline LLCAbandonedAbandoned Sep 24, 2013
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited